SavedAdd your journal

Journals / Acta Orthopaedica et Traumatologica Turcica / 2014 / Cilt: 48 - Sayı: 1

Efficacy of 5-Fluorouracil in inhibition of unintended bone formation in spinal surgery: a histological evaluation on a rat model of spontaneous spinal fusion ( EXPERIMENTAL STUDY)

Esat KITER
Ertan ER
Nilay TÜRK ŞEN
Murat OTO
Semih AKKAYA
Pages
86–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that after further studies on its local delivery dose, it can be used in humans for inhibition of unintended fusion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the influence of the antiproliferative agent 5-Fluorouracil (5FU) over inhibition of spinal bone formation in an experimental rat model.
📊
Key Findings & Data:Methods: The study included 30 6-month-old Sprague-Dawley rats divided into 3 groups.
💡
Conclusion & Impact:We believe that after further studies on its local delivery dose, it can be used in humans for inhibition of unintended fusion.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate the influence of the antiproliferative agent 5-Fluorouracil (5FU) over inhibition of spinal bone formation in an experimental rat model. Methods: The study included 30 6-month-old Sprague-Dawley rats divided into 3 groups. Aggressive periosteal denuding was performed by scalpel to induce punctuate bleeding in the posterior elements of the L4-L5 vertebrae in the spontaneous fusion model. Spinous processes were fixated by wires and no graft substitute was applied. Adcon-L was applied in Group 1, single-touch technique 5FU in Group 2. Group 3 was the control group. Rats were sacrificed at 4 weeks and specimens acquired for histological examination. Results: 5FU substantially inhibited fibroblast and inflammatory cell densities as well as bone formation compared to the control group. 5FU was considerably superior to Adcon-L with regard to inhibition of bone formation and inflammatory cells (p=0.0001). Conclusion: 5FU can inhibit fusion, fibrosis and unwanted scar tissue in spinal surgery. We believe that after further studies on its local delivery dose, it can be used in humans for inhibition of unintended fusion.

🔖

Cite This Article

KITER, E., ER, E., ŞEN, N. T., OTO, M., AKKAYA, S. (2014). Efficacy of 5-Fluorouracil in inhibition of unintended bone formation in spinal surgery: a histological evaluation on a rat model of spontaneous spinal fusion ( EXPERIMENTAL STUDY). Acta Orthopaedica et Traumatologica Turcica, Cilt: 48 - Sayı: 1, 86–91. https://ajindex.com/articles/353596

References (14)

  1. Mardjetko SM, Hammerberg KW, Lubicky JP, Fister JS. The Luque trolley revisited. Review of nine cases requiring revision. Spine 1992;17:582-9
  2. Blakemore LC, Scoles PV, Poe-Kochert C, Thompson GH. Submuscular Isola rod with or without limited apical fusion in the management of severe spinal deformities in young children: preliminary report. Spine 2001;26:2044- 8
  3. Acaroglu E, Yazici M, Alanay A, Surat A. Three-dimensional evolution of scoliotic curve during instrumentation without fusion in young children. J Pediatr Orthop 2002;22:492-6
  4. Moe JH, Kharrat K, Winter RB, Cummine JL. Harrington instrumentation without fusion plus external orthotic support for the treatment of difficult curvature problems in young children. Clin Orthop Relat Res 1984;185:35- 45
  5. Eberle CF. Failure of fixation after segmental spinal instrumentation without arthrodesis in the management of paralytic scoliosis. J Bone Joint Surg Am 1988;70:696-703
  6. Fisk JR, Peterson HA, Laughlin R, Lutz R. Spontaneous fusion in scoliosis after instrumentation without arthrodesis. J Pediatr Orthop 1995;15:182-6
  7. Cahill PJ, Marvil S, Cuddihy L, Schutt C, Idema J, Clements DH, et al. Autofusion in the immature spine treated with growing rods. Spine 2010;35:E1199-203
  8. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002;27(16 Suppl 1):40-8
  9. Patel VV, Zhao L, Wong P, Kanim L, Bae HW, Pradhan BB, et al. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. Spine 2006;31:1201-6
  10. Patel VV, Zhao L, Wong P, Pradhan BB, Bae HW, Kanim L, et al. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Spine J 2006;6:397-404
  11. Zou X, Li H, Egund N, Lind M, Bünger C. Inhibition of spinal fusion by use of a tissue ingrowth inhibitor. Eur Spine J 2004;13:157-63
  12. Abiraman S, Varma HK, Umashankar PR, John A. Fibrin glue as an osteoinductive protein in a mouse model. Biomaterials 2002;23:3023-31
  13. Khan U, Occleston NL, Khaw PT, McGrouther DA. Single exposures to 5-fluorouracil: a possible mode of targeted therapy to reduce contractile scarring in the injured tendon. Plast Reconstr Surg 1997;99:465-71
  14. He Y, Revel M, Loty B. A quantitative model of post-laminectomy scar formation. Effects of a nonsteroidal antiinflammatory drug. Spine 1995;20:557-63; disc